We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
-4.95%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.9B
AUM Growth
-$320M
Cap. Flow
-$202M
Cap. Flow %
-10.62%
Top 10 Hldgs %
7.71%
Holding
2,190
New
419
Increased
603
Reduced
646
Closed
510

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$17.7M
2
SBUX icon
Starbucks
SBUX
+$16.5M
3
WMB icon
Williams Companies
WMB
+$15.6M
4
HRI icon
Herc Holdings
HRI
+$14.9M
5
DAL icon
Delta Air Lines
DAL
+$14M

Sector Composition

Rank Sector Weight
1 Healthcare 14.76%
2 Consumer Discretionary 13.95%
3 Industrials 12.6%
4 Technology 11%
5 Energy 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WEN icon
1626
Wendy's
WEN
$1.46B
$94K ﹤0.01%
11,359
-52,854
-82% -$433K
PSTB
1627
DELISTED
Park Sterling Corp.
PSTB
$93K ﹤0.01%
13,971
-28,961
-67% -$197K
TTMI icon
1628
TTM Technologies
TTMI
$13.8B
$92K ﹤0.01%
13,528
-31,900
-70% -$242K
CBR
1629
DELISTED
CIBER Inc.
CBR
$90K ﹤0.01%
26,372
-11,749
-31% -$46.4K
SKYW icon
1630
Skywest
SKYW
$4.56B
$89K ﹤0.01%
11,425
-19,200
-63% -$195K
ATRS
1631
DELISTED
Antares Pharma, Inc.
ATRS
$88K ﹤0.01%
+48,000
New +$105K
MIG
1632
DELISTED
MEADOWBROOK INSURANCE GRP INC
MIG
$85K ﹤0.01%
+14,600
New +$91.6K
ATSG
1633
DELISTED
Air Transport Services Group
ATSG
$84K ﹤0.01%
+11,516
New +$94.6K
CAA
1634
DELISTED
CalAtlantic Group, Inc.
CAA
$84K ﹤0.01%
2,234
-280
-11% -$11.3K
CMLS
1635
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$80K ﹤0.01%
+2,475
New +$98.1K
SGYP
1636
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$77K ﹤0.01%
+27,500
New +$99.8K
MCHX icon
1637
Marchex
MCHX
$83.3M
$73K ﹤0.01%
17,640
-4,357
-20% -$40.6K
ATHX
1638
DELISTED
Athersys, Inc. Common Stock
ATHX
$73K ﹤0.01%
+2,104
New +$80.6K
GLDD
1639
DELISTED
Great Lakes Dredge & Dock
GLDD
$71K ﹤0.01%
+11,500
New +$84.9K
RITM icon
1640
Rithm Capital
RITM
$5.72B
$71K ﹤0.01%
+6,131
New +$76.2K
MEA
1641
DELISTED
METALICO INC
MEA
$70K ﹤0.01%
63,355
BLDP
1642
Ballard Power Systems
BLDP
$826M
$69K ﹤0.01%
21,400
+10,878
+103% +$41K
ENZ
1643
DELISTED
Enzo Biochem, Inc.
ENZ
$69K ﹤0.01%
13,345
-20,748
-61% -$111K
HGG
1644
DELISTED
hhgregg Inc.
HGG
$68K ﹤0.01%
+10,700
New +$81.4K
AXTI icon
1645
AXT Inc
AXTI
$4.27B
$66K ﹤0.01%
27,199
NETI
1646
DELISTED
Eneti Inc.
NETI
$63K ﹤0.01%
+97
New +$85.9K
ACI
1647
DELISTED
ARCH COAL, INC.
ACI
$63K ﹤0.01%
+2,971
New +$89K
LUB
1648
DELISTED
Luby's Inc.
LUB
$62K ﹤0.01%
+11,581
New +$60.9K
HOV icon
1649
Hovnanian Enterprises
HOV
$799M
$61K ﹤0.01%
+661
New +$69.8K
KEG
1650
DELISTED
KEY ENERGY SERVICES INC
KEG
$61K ﹤0.01%
12,509
-110,571
-90% -$539K

Similar funds

GSA Capital Partners's Q3 2014 Portfolio in Review

As of Q3 2014, GSA Capital Partners held 2,190 positions worth $1.9B, down 14% from $2.22B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.

GSA Capital Partners withdrew a net $202M in Q3 2014, closing 510 positions and reducing 646 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, GSA Capital Partners opened a new position in Illumina worth $16.9M.

  • GSA Capital Partners's largest Q3 2014 buy was Illumina: 105,983 shares worth $16.9M.
  • GSA Capital Partners added most to Williams Companies in Q3 2014, an estimated $15.6M increase.
  • GSA Capital Partners's biggest Q3 2014 reduction was Marathon Petroleum, cutting an estimated $24.9M.
  • GSA Capital Partners fully exited Regeneron Pharmaceuticals in Q3 2014, selling an estimated $15.2M.
  • GSA Capital Partners's ten largest holdings make up 7.7% of its $1.9B portfolio in Q3 2014.
  • GSA Capital Partners opened 419 new positions and closed 510 in Q3 2014.
  • GSA Capital Partners's portfolio value fell 14% quarter-over-quarter to $1.9B.

Based on GSA Capital Partners's 13F filing for Q3 2014, filed 6 Nov 2014.